Compound 17 (quercetin-3-methyl ether) interacted with multiple key targets related to pancreatic cancer, including AKT1, EGFR, TNF, CASP3, and SRC, and occupies a central position within the PPI network, indicating the potential regulatory interaction. The gene discussed is EGFR; the disease is pancreatic neoplasm.